Ditchcarbon
  • Contact
  1. Organizations
  2. Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Public Profile
Pharmaceutical Preparation Manufacturing
CN
updated a month ago

Shijiazhuang Yiling Pharmaceutical Co., Ltd. Sustainability Profile

Company website

Shijiazhuang Yiling Pharmaceutical Co., Ltd., commonly referred to as Yiling Pharmaceutical, is a leading player in the Chinese pharmaceutical industry, headquartered in Shijiazhuang, CN. Established in 1992, the company has made significant strides in the development and production of traditional Chinese medicine and modern pharmaceuticals, focusing on areas such as cardiovascular health, oncology, and respiratory diseases. Yiling Pharmaceutical is renowned for its innovative core products, including the widely acclaimed Yiling Qingfei Paidu Decoction, which exemplifies the integration of traditional practices with contemporary science. With a strong commitment to research and development, the company has achieved notable milestones, positioning itself as a trusted name in both domestic and international markets. Its dedication to quality and efficacy has earned Yiling Pharmaceutical a prominent market position, making it a key contributor to the advancement of healthcare solutions.

DitchCarbon Score

How does Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

22

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s score of 22 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.

20%

Let us know if this data was useful to you

Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s reported carbon emissions

Shijiazhuang Yiling Pharmaceutical Co., Ltd., headquartered in CN, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing its carbon footprint at this time. As there are no emissions data or reduction initiatives available, it is unclear how Shijiazhuang Yiling Pharmaceutical aligns with industry standards for climate action. The absence of specific targets or commitments may reflect a broader trend within the pharmaceutical sector, where companies are increasingly being called upon to disclose their environmental impact and set ambitious sustainability goals. Overall, without concrete emissions data or reduction strategies, Shijiazhuang Yiling Pharmaceutical's climate commitments remain undefined, highlighting an opportunity for the company to enhance its environmental accountability and align with global climate initiatives.

How Carbon Intensive is Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Shijiazhuang Yiling Pharmaceutical Co., Ltd. is in CN, which we do not have grid emissions data for.

Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Shijiazhuang Yiling Pharmaceutical Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Shijiazhuang Yiling Pharmaceutical Co., Ltd.'s Emissions with Industry Peers

Tasly Holding Group Company. ltd.

CN
•
Financial intermediation services, except insurance and pension funding services (65)
Updated 1 day ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Tasly Pharmaceutical Group Co., Ltd

CN
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Beijing Tongrentang Co., Ltd

CN
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

CN
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251114.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
AWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy